Cerevel Therapeutics Holdings Inc(CERE)
$44.62▲0.5%
Market is closed - opens 7 PM, 29 Jul 2024
Insights
- Cerevel Therapeutics Holdings Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Cerevel Therapeutics Holdings Inc stock suggests that it is a good time to sell or bad time to initiate a fresh position
- Based on analysis of the Moving Averages technical indicator, Cerevel Therapeutics Holdings Inc stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for Cerevel Therapeutics Holdings Inc stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 71.05 | Sell |
Stochastic | 96.98, 95.26 | Neutral |
Ultimate Oscillator | 72.24 | Sell |
Stochastic Relative Strength Index | 98.06, 98.48 | Sell |
Moving Average Convergence Divergence | 0.71, 0.4 | Buy |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 42.76 | Buy |
20 | 41.8 | Buy |
50 | 41.41 | Sell |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 42.92 | Buy |
20 | 42.23 | Buy |
50 | 41.72 | Buy |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 43.09 | Neutral |
20 | 41.76 | Buy |
50 | 41.39 | Buy |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 43.84 | Buy |
20 | 43.06 | Buy |
50 | 41.97 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 44.18 | Buy |
20 | 43.73 | Buy |
50 | 42.3 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 43.62 |
Resistance L2 | 43.56 |
Resistance L1 | 43.46 |
Pivot Point | 43.4 |
Support L1 | 43.3 |
Support L2 | 43.24 |
Support L3 | 43.14 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.